HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2307
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing ; volume:457 ; number:3 ; day:28 ; month:7 ; year:2010 ; pages:299-307 ; date:9.2010
Virchows Archiv ; 457, Heft 3 (28.7.2010), 299-307, 9.2010
- Creator
-
Rüschoff, Josef
Dietel, Manfred
Baretton, Gustavo
Arbogast, Susanne
Walch, Axel
Monges, Geneviéve
Chenard, Marie-Pierre
Penault-Llorca, Frédérique
Nagelmeier, Iris
Schlake, Werner
Höfler, H.
Kreipe, H. H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-010-0952-2
- URN
-
urn:nbn:de:101:1-2019111712185080163361
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rüschoff, Josef
- Dietel, Manfred
- Baretton, Gustavo
- Arbogast, Susanne
- Walch, Axel
- Monges, Geneviéve
- Chenard, Marie-Pierre
- Penault-Llorca, Frédérique
- Nagelmeier, Iris
- Schlake, Werner
- Höfler, H.
- Kreipe, H. H.
- SpringerLink (Online service)
Other Objects (12)
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
The German guideline on medical clinical diagnostics for indoor mold exposure: key messages
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Abridged Version of the AWMF-Guideline for the medical clinical Diagnostics of Indoor Mould Exposure
Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival